title: Diabetes and development of tardive dyskinesia.
abstract: Diabetes mellitus has been identified as a possible risk factor for tardive dyskinesia. The authors examined 160 elderly individuals who were beginning neuroleptic treatment; 24 had diabetes and 136 did not. After 43 weeks of neuroleptic exposure, the cumulative incidence rates of tardive dyskinesia were 54.1% (SE = 5.6%) for the diabetics and 25.6% (SE = 16.1%) for the nondiabetics.
authors.affiliation: Department of Psychiatry, Hillside Hospital, Long Island Jewish Medical Center, Glen Oaks, NY 11004.
authors.forename: M G
authors.initials: MG
authors.lastname: Woerner
authors.forename: B L
authors.initials: BL
authors.lastname: Saltz
authors.forename: J M
authors.initials: JM
authors.lastname: Kane
authors.forename: J A
authors.initials: JA
authors.lastname: Lieberman
authors.forename: J M
authors.initials: JM
authors.lastname: Alvir
mesh_terms: D000367:Age Factors; D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects*; D048909:Diabetes Complications; D004409:Dyskinesia, Drug-Induced / Q000150:complications / Q000453:epidemiology* / Q000209:etiology; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D011446:Prospective Studies; D012307:Risk Factors
chemical_list: D014150:Antipsychotic Agents